Back to search

Switzerland· 67614001

Rayaldee 30 µg, Weichkapseln retardiert

A calcifediol product containing calcifediolum, registered in Switzerland by Vifor Fresenius Medical Care Renal Pharma Ltd. and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC H05BX05

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedRayaldee 30 µg, Weichkapseln retardie…ATCH05BX05REGISTER NO.67614001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Calcifediol is registered in 6 of 19 countries.

Countries holding a registration under ATC H05BX05 (calcifediol), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 2 of them publish a price we can compare per daily dose

Calcifediol · ATC H05BX05

6 / 19 countries

  • Denmark
  • Germany
  • Netherlands
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of calcifediol costs, country by country.

Normalised to the WHO defined daily dose (30 mcg), so markets compare like for like.

  • Switzerland: $4.51 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Calcifediol · price per daily dose (30 mcg)

USD · FX 28 Sept 2026

  • CH Switzerland$4.51
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
calcifediolum
Manufacturer
Vifor Fresenius Medical Care Renal Pharma Ltd.
Country
Switzerland (CH)
ATC code
H05BX05
ATC class
Calcifediol
Defined daily dose
30 mcg, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680676140014
    Fl 30 Stk
    CHF 112.3

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

68 interactions on record for calcifediol.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Calcifediol · interactions on record

68 records

  • 10 severe
  • 57 moderate
  • 1 minor

Most severe, free to view

  • ErgocalciferolA11CC01severe
  • DihydrotachysterolA11CC02severe
  • CalcitriolA11CC04severe
  • ColecalciferolA11CC05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Calcifediol in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All calcifediol products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Hidroferol
  • Belgium · Dédrogyl, Defediol
  • Bulgaria · Хидроферол
  • Czechia · Uperold
  • Germany · Dedrogyl, Rayaldee
  • Denmark · Defevix, Rayaldee
  • Estonia · Defevix, Hidrosun
  • Spain · Calcifediol Normogen, Calcifediol Normon
  • Finland · Defevix
  • France · Calcifediol Desma, Calcifediol Gerda
  • United Kingdom (Northern Ireland) · Domnisol
  • Greece · D Ready, Hidroferol
  • Croatia · Defevix, Tryde
  • Hungary · Defevix
  • Ireland · Calcifediol Faes, Dnord
  • Italy · Didrogyl, Hercal
  • Lithuania · Calcifediol Faes, Defevix
  • Luxembourg · Defediol, Hidroferol Hebdomadaire
  • Latvia · Defevix
  • Netherlands · Dediol Wekelijks, Hidroferol
  • Norway · Defevix, Hidrosun
  • Poland · Calfos, Devisol-25
  • Portugal · Dedrogyl, Dvit
  • Romania · Hidroferol
  • Sweden · Defevix, Rayaldee
  • Slovenia · Defevix, Kalcifediol Faes
  • Slovakia · Defevix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9786d14b-5734-48b0-bb65-8aa859513622
GET /v1/drugs/9786d14b-5734-48b0-bb65-8aa859513622?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "calcifediolum 30 mcg",
  "valid_from": "2025-04-01",
  "limitations": "[{\"description\":\"Zur Behandlung des sekundären Hyperparathyreoidismus (SHPT) mit iPTH-Plasmaspiegeln zwischen ≥85 und <500 pg/ml bei erwachsenen Patienten mit einer chronischen Nierenerkrankung Stadium 3 oder 4 und Vitamin D-Serumkonzentration <30 ng/ml.<br>\\nVor der Einleitung der Behandlung sollte das Serumkalzium unter 2.45 mmol/L (9.8 mg/dl) und das Serumphosphat unter 1.78 mmol/L (5.5 mg/dl) liegen.<br>\\nDie Diagnosestellung sowie die Verschreibung müssen durch einen Facharzt der Nephrologie erfolgen.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2025-04-01\",\"validTo\":\"2028-03-31\"}]",
  "galenic_form": "Kaps 30 mcg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2022-03-01",
  "self_retention_pct": 10
}

See everything about calcifediol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.